KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Long-Term Deferred Tax (2016 - 2025)

Edwards Lifesciences has reported Long-Term Deferred Tax over the past 17 years, most recently at $1.1 billion for Q4 2025.

  • Quarterly results put Long-Term Deferred Tax at $1.1 billion for Q4 2025, up 14.72% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (up 14.72% YoY), and the annual figure for FY2025 was $1.1 billion, up 14.72%.
  • Long-Term Deferred Tax for Q4 2025 was $1.1 billion at Edwards Lifesciences, up from $1.1 billion in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for EW hit a ceiling of $1.1 billion in Q4 2025 and a floor of $184.0 million in Q3 2021.
  • Median Long-Term Deferred Tax over the past 5 years was $631.3 million (2023), compared with a mean of $632.9 million.
  • Biggest five-year swings in Long-Term Deferred Tax: dropped 14.5% in 2021 and later skyrocketed 98.54% in 2023.
  • Edwards Lifesciences' Long-Term Deferred Tax stood at $246.7 million in 2021, then skyrocketed by 96.19% to $484.0 million in 2022, then surged by 54.83% to $749.4 million in 2023, then skyrocketed by 32.39% to $992.1 million in 2024, then grew by 14.72% to $1.1 billion in 2025.
  • The last three reported values for Long-Term Deferred Tax were $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025) per Business Quant data.